Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q6MA
|
|||
| Former ID |
DIB001075
|
|||
| Drug Name |
Gamma-sarcoglycan gene-containing recombinant AAV1 vector based therapy
|
|||
| Synonyms |
Gamma-sarcoglycan gene-containing recombinant AAV1vector based therapy (limb-girdle muscular dystrophy type 2C)
Click to Show/Hide
|
|||
| Indication | Duchenne dystrophy [ICD-11: 8C70; ICD-10: G71.0] | Phase 2 | [1] | |
| Company |
Genethon
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors. Curr Gene Ther. 2012 Jun;12(3):139-51. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.